NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 58.00

+3.6%

Nov 10 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Arthur Radley	7/24/2010 9:10:01 PM
	Read Replies (1) of 507

Roche reported Q results this week....they indicated Mircera revenue was up to 124M(SW Fr)showing revenue is ramping up nicely. The drug has been approved here in the US by the FDA, but Amgen ligation has it on hold. Considering NKTR has a deal with Roche on this drug, can anyone add any color to the potential for them eventually get the drug on the market here in the US? If EU sales are good indicators.....would be a big plus for NKTR (IMO).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next